2 completed, 1 suspended, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Suspended 1, Unknown 1 |
Follow Triangle Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART emtricitabine, FTC (drug), didanosine, ddI (drug), efavirenz (drug) - HIV Infections | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 350 | 2001-04-01 | 2026-06-15 |
| A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs Efavirenz, Emtricitabine, Stavudine - HIV Infections | Phase 3 | Unknown | Triangle Pharmaceuticals | 2000-08-01 | 2005-06-24 | |
| A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs Abacavir sulfate, Efavirenz, Emtricitabine - HIV Infections | Phase 3 | Suspended | Triangle Pharmaceuticals | 1999-08-01 | 2005-06-24 | |
| Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination Emtricitabine, Lamivudine - HIV Infections | Phase 3 | Completed | Triangle Pharmaceuticals | 390 | 2005-06-24 |
HIV Infections (4)
Emtricitabine (4) · efavirenz (3) · Didanosine (2) · Stavudine (2) · Lamivudine (1) · Pharmaceutical Preparations (1) · Racivir (1) · abacavir (1)
United States (3) · Argentina (1) · Canada (1) · Chile (1) · France (1) · Mexico (1) · Puerto Rico (1)
Charles van der Horst (1) · Genevieve Chene, MD, PhD (1) · Jean-Michel Molina, MD, PhD (1)